Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.130
-0.010 (-0.88%)
At close: Mar 31, 2026, 4:00 PM EDT
1.180
+0.050 (4.42%)
After-hours: Mar 31, 2026, 5:22 PM EDT

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
606.14
Revenue / Employee
$2,273
Employees
22
Market Cap
30.04M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evaxion7.53M
CervoMed4.01M
Dyadic International3.09M
Pluri1.34M
Hyperion DeFi813.46K
Exicure500.00K
Actinium Pharmaceuticals90.00K
Revenue Rankings

INMB News

More News